Evidence map›Paper›PMID 35308316›Full record

ArticleNordisk alkohol- & narkotikatidskrift : NAT2020

Opioid maintenance treatment of pregnant women in the Scandinavian countries.

Marte Handal, Svetlana Skurtveit, Milada Mahic, Inger Øhman, Birgitta Norstedt Wikner, Christian Tjagvad, Helle Kieler, Erja Halmesmäki, Ingunn Olea Lund

Open access · diamondAbstract read
In one paragraph

Article in Nordisk alkohol- & narkotikatidskrift : NAT, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Who is an expert on the COVID-19 crisis?Nordisk alkohol- & narkotikatidskrift : NAT · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Marte HandalDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.ORCID https://orcid.org/0000-0003-1773-0184
Svetlana SkurtveitDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Milada MahicDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Inger ØhmanCentre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Birgitta Norstedt WiknerCentre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Christian TjagvadNorwegian Centre for Addiction Research (SERAF), University of Oslo, Norway.
Helle KielerCentre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Erja HalmesmäkiDepartment of Obstetrics and Gynaecology, Helsinki University, Helsinki, Finland.
Ingunn Olea LundDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Norwegian Institute of Public Health · NOKarolinska Institutet · SEUniversity of Helsinki · FIUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: WHO guidelines emphasise the need for descriptions of clinical practice and observational studies on risk and benefits of pharmacotherapies in pregnancy. The aims of the present study were to: (1) Describe opioid maintenance treatment (OMT) in the Scandinavian countries in general, and specifically for pregnant women, (2) Describe a project which utilises a new approach using registry-linkage data to examine associations between prenatal exposure to OMT and child outcomes: a Scandinavian cohort study of pregnant women in OMT during pregnancy (ScopeOMT). Data: Guidelines describing the treatment of persons with opioid use disorders in general, and specifically for pregnant women. Scandinavian registry-linkage data from ScopeOMT. Results: Registry data show that approximately 800 pregnant women received OMT during pregnancy in the period of the ScopeOMT study. Similarities across the Scandinavian countries include access to free healthcare and treatment; multidisciplinary teams trained to support pregnant women in OMT; buprenorphine as the recommended drug when initiating therapy; and a holistic focus on the patients' lives. An important difference is that Norwegian women who use illegal substances that may harm the foetus may be admitted - voluntarily, or against their will - for parts of, or the remainder of the pregnancy to inpatient treatment at specialised clinics. Conclusion: Many similarities in the treatment provided to opioid-dependent persons in the Scandinavian countries place this area in an excellent position to combine the efforts and carry out observational studies concerning the safety of OMT during pregnancy.

Indexed as

buprenorphinechildDenmarkfoetusguidelinesmethadoneNorwayopioid maintenance treatmentpregnancySweden

Identifiers

PMID35308316
PMCPMC8899263
OpenAlexW3016684382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.